We are live on ! Find out more
Adage Capital Partners

Adage Capital Partners Portfolio holdings

AUM $64.8B
1-Year Est. Return 42.7%
This Fund
S&P 500
This Quarter Est. Return
+1.09%
1 Year Est. Return
+42.7%
3 Year Est. Return
+139.29%
5 Year Est. Return
+204.38%
10 Year Est. Return
+829.83%
AUM
$50.8B
AUM Growth
-$294M
Cap. Flow
-$328M
Cap. Flow %
-0.65%
Top 10 Hldgs %
22.21%
Holding
1,137
New
127
Increased
273
Reduced
442
Closed
122

Top Buys

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$255M
2
TXT icon
Textron
TXT
+$206M
3
AZN icon
AstraZeneca
AZN
+$164M
4
XOM icon
ExxonMobil
XOM
+$124M
5
MRNA icon
Moderna
MRNA
+$121M

Sector Composition

Rank Sector Weight
1 Technology 22.3%
2 Healthcare 15.98%
3 Financials 14.49%
4 Consumer Discretionary 11.52%
5 Communication Services 8.72%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CSX icon
176
CSX Corp
CSX
$92.3B
$59.9M 0.12%
2,015,304
-103,700
-5% -$3.32M
F icon
177
Ford
F
$57.5B
$59.6M 0.12%
4,211,600
-48,500
-1% -$660K
O icon
178
Realty Income
O
$59.2B
$59.5M 0.12%
947,273
+69,041
+8% +$4.66M
FITB
179
Fifth Third Bancorp
FITB
$51.6B
$59.3M 0.12%
1,398,126
-111,836
-7% -$4.28M
BDX icon
180
Becton Dickinson
BDX
$46.9B
$59.1M 0.12%
246,425
-76,260
-24% -$18.7M
JCI icon
181
Johnson Controls International
JCI
$88.7B
$58.9M 0.12%
864,715
-768,721
-47% -$55.5M
FLYW icon
182
Flywire
FLYW
$2.05B
$58.1M 0.11%
1,324,809
-185,000
-12% -$7.21M
ETN icon
183
Eaton
ETN
$170B
$57.9M 0.11%
387,798
-13,799
-3% -$2.21M
REGN icon
184
Regeneron Pharmaceuticals
REGN
$78.2B
$57.8M 0.11%
95,484
-1,222
-1% -$759K
ADSK icon
185
Autodesk
ADSK
$49.6B
$57.7M 0.11%
202,489
-35,900
-15% -$11M
MET icon
186
MetLife
MET
$62B
$57.5M 0.11%
931,926
+118,800
+15% +$7.15M
AEP icon
187
American Electric Power
AEP
$69.9B
$57.5M 0.11%
708,406
-116,244
-14% -$10.1M
FDX icon
188
FedEx
FDX
$73.2B
$57.3M 0.11%
261,504
-3,800
-1% -$1.03M
IDXX icon
189
Idexx Laboratories
IDXX
$44.8B
$57M 0.11%
91,601
-1,188
-1% -$798K
CCJ icon
190
Cameco
CCJ
$39.1B
$57M 0.11%
2,621,089
+600,000
+30% +$11.4M
GCMG icon
191
GCM Grosvenor
GCMG
$795M
$56.9M 0.11%
4,942,786
SBNY
192
DELISTED
Signature Bank
SBNY
$56.8M 0.11%
208,696
+153,070
+275% +$38.4M
WCC
193
WESCO International
WCC
$17.6B
$56.8M 0.11%
492,118
-108,767
-18% -$12M
DXCM icon
194
DexCom
DXCM
$32.9B
$56.8M 0.11%
415,100
-2,000
-0.5% -$252K
CMA
195
DELISTED
Comerica
CMA
$56.3M 0.11%
699,219
-496,531
-42% -$35.7M
KEY icon
196
KeyCorp
KEY
$24.5B
$56.1M 0.11%
2,596,769
+790,300
+44% +$16M
RARE icon
197
Ultragenyx Pharmaceutical
RARE
$2.46B
$55.9M 0.11%
620,000
+360,000
+138% +$32.5M
SNDX icon
198
Syndax Pharmaceuticals
SNDX
$1.7B
$54.8M 0.11%
2,866,272
+375,000
+15% +$6.25M
CMG icon
199
Chipotle Mexican Grill
CMG
$47.4B
$54.5M 0.11%
1,499,950
-20,000
-1% -$728K
HUM icon
200
Humana
HUM
$45B
$53.7M 0.11%
137,910
-2,000
-1% -$849K

Similar funds

Adage Capital Partners's Q3 2021 Portfolio in Review

As of Q3 2021, Adage Capital Partners held 1,137 positions worth $50.8B, down 0.58% from $51.1B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Adage Capital Partners's Q3 2021 filing shows 127 new, 273 increased, 442 reduced and 122 closed positions. Its largest new stake was Pfizer: 5,759,101 shares worth $248M. The largest sale was Alexion Pharmaceuticals, an estimated $962M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 22% a quarter earlier, followed by Healthcare and Financials.

  • Adage Capital Partners's largest Q3 2021 buy was Pfizer: 5,759,101 shares worth $248M.
  • Adage Capital Partners added most to Textron in Q3 2021, an estimated $206M increase.
  • Adage Capital Partners's biggest Q3 2021 reduction was Devon Energy, cutting an estimated $201M.
  • Adage Capital Partners fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $962M.
  • Adage Capital Partners's ten largest holdings make up 22% of its $50.8B portfolio in Q3 2021.
  • Adage Capital Partners opened 127 new positions and closed 122 in Q3 2021.
  • Adage Capital Partners's portfolio value fell 0.58% quarter-over-quarter to $50.8B.

Based on Adage Capital Partners's 13F filing for Q3 2021, filed 15 Nov 2021.